Details of the Drug

General Information of Drug (ID: DMZ1CJL)

Drug Name
KRL-401
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Phase 1 [1]
Cross-matching ID
TTD ID
D0I3BS

References

1 Pharmaceutical Research Companies Are Developing Nearly 200 Medicines to Treat Mental Illnesses and Addictive Disorders. Pharmaceutical Research and Manufacturers of America report. 2012.